ANEB: Anebulo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.12
Enterprise Value ($M) 36.72
Book Value ($M) 1.90
Book Value / Share 0.07
Price / Book 20.08
NCAV ($M) 1.39
NCAV / Share 0.05
Price / NCAV 27.36

Profitability (mra)
Return on Invested Capital (ROIC) -4.17
Return on Assets (ROA) -0.88
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 3.45

Balance Sheet (mrq) ($M)
Current Assets 1.96
Assets 2.47
Liabilities 0.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.31
Net Income -8.20

Cash Flow Statement (mra) ($M)
Cash From Operations -8.09
Cash from Investing 0.00
Cash from Financing -0.06

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-09-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 264 3,279 8.05
2024-11-21 2,968 13,854 21.42
2024-11-20 49 3,547 1.38
2024-11-19 1,535 1,718 89.35
2024-11-18 45 330 13.64

(click for more detail)

Similar Companies
ALRN – Aileron Therapeutics, Inc. ALVR – AlloVir, Inc.
ALZN – Alzamend Neuro, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited


Financial data and stock pages provided by
Fintel.io